NOVARTIS PHARMACEUTICALS CORPORATION

Entity uei:NG61ZA8TADW3 · UEI NG61ZA8TADW3

About this data

Bounded ingest, not a census: 29,750 contract awards currently loaded (1,593 with full transaction history), per the scope in outlay.config.json. Totals are totals of the ingested set.
Dollar amounts are obligations — money the government has promised to pay, not cash already out the door. Agencies report this data themselves; the Defense Department publishes ~90 days late; the current budget year is still in progress. See methodology.
Outlay (paid-out) figures cover only awards that link between contract records and agency financial reports: for Department of Veterans Affairs, 1,648 of 5,855 reported contracts ($32.3B of $48.5B in FY2026 gross outlays) as of FY2026 period 9. Awards without a link show obligations only — that is a coverage fact, not a spending fact.
Source records republish silently; Outlay keeps its own append-only version archive from first pull onward. Post-publication revisions recorded so far: 2,258 awards (2,273 revisions). Revisions are routine (spending progresses, errors get corrected) and are not themselves evidence of anything.

Last ingest run #21 (running) started Sep 6, 2026, 12:40 UTC — 0 awards, 0 details, 0 transactions.

Obligations by fiscal year

FY2025

$4.6M

FY2026

$26.4M

Awards (15)


36C24826F0082 ↗ PLUVICTO	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Feb 24, 2026 – Aug 31, 2026	$4.7M	—
36C25726N0205 ↗ LU177 - PLUVICTO/LUTATHERA	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Feb 7, 2026 – Feb 6, 2027	$4.2M	—
36C26126F0007 ↗ PLUVICTO DRUG	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Oct 1, 2025 – Sep 30, 2026	$4.0M	—
36C26226N0112 ↗ PLUVICTO AND LUTATHERA	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Nov 1, 2025 – Oct 31, 2026	$3.9M	—
36C25725N0190 ↗ LUTATHERA & PLUVICTO	Department of Veterans Affairs Department of Veterans Affairs	FY2025	Feb 7, 2025 – Feb 6, 2026	$2.7M	—
36C25026N0310 ↗ RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Feb 1, 2026 – Dec 31, 2026	$2.4M	—
36C24426F0063 ↗ RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Jan 1, 2026 – Dec 31, 2026	$2.0M	—
36C25225F0191 ↗ DELIVERY ORDER FOR A BASE PLUS ONE (1) OPTION YEAR FOR THE RADIOPHARMACEUTICAL PLUVICTO.	Department of Veterans Affairs Department of Veterans Affairs	FY2025	Sep 1, 2025 – Aug 31, 2027	$1.7M	—
36C26126F0017 ↗ PLUVICTO FY26	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Oct 1, 2025 – Sep 30, 2026	$1.6M	—
36C25026N0006 ↗ PLUVICTO	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Oct 1, 2025 – Sep 30, 2026	$1.2M	—
36C26126F0168 ↗ PLUVICTO - LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Apr 1, 2026 – Sep 30, 2026	$1.0M	—
36C26226F0048 ↗ PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Jan 2, 2026 – Jan 1, 2027	$1.0M	—
36C24826N0026 ↗ GA-68 DOTATATE (NETSPOT)	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Oct 1, 2025 – Sep 30, 2026	$172K	—
36C25225N0482 ↗ LUTATHERA - LUTETIUM LU 177 DOTATATE	Department of Veterans Affairs Department of Veterans Affairs	FY2025	Aug 1, 2025 – Aug 26, 2026	$169K	—
36C26226N0271 ↗ VA GLA NETSPOT	Department of Veterans Affairs Department of Veterans Affairs	FY2026	Jan 3, 2026 – Dec 31, 2026	$161K	—

Observed spellings (1)

Raw recipient names from source records that resolved to this entity.

NOVARTIS PHARMACEUTICALS CORPORATIONNG61ZA8TADW3 · seen 65×